EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹35.96 | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 |
What is the latest Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹35.96 |
| Mar2024 | ₹27.50 |
| Mar2023 | ₹29.42 |
| Mar2022 | ₹36.62 |
| Mar2021 | ₹21.68 |
How is Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹35.96 | 30.76 | |
| Mar2024 | ₹27.50 | -6.53 | |
| Mar2023 | ₹29.42 | -19.66 | |
| Mar2022 | ₹36.62 | 68.91 | |
| Mar2021 | ₹21.68 | - | |
Compare Earnings Per Share (EPS) of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹30,350.2 Cr | 3.1% | 5.3% | 55% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.1% |
5.3% |
55% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses